Najar, Tariq A.
Hao, Yuan
Hao, Yuhan
Romero-Meza, Gabriela
Dolynuk, Alexandra
Almo, Emma
Littman, Dan R. https://orcid.org/0000-0002-2850-8688
Article History
Received: 26 August 2024
Accepted: 13 November 2025
First Online: 14 January 2026
Competing interests
: D.R.L. is co-founder of Vedanta Biosciences and ImmunAI, on the advisory boards of Nilo Therapeutics, IMIDomics, Sonoma Biotherapeutics and Evommune, and on the board of directors of Pfizer Inc. Yuhan Hao is co-founder and equity holder of Neptune Bio. The other authors declare no competing interests.